The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive modeling by tumor type: Comparing performance and feature importance of machine learning–based predictive models in patients with hematologic and solid tumors.
 
Eashwar Somasundaram
No Relationships to Disclose
 
Patrick Johnson
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bristol Myers Squibb; Cardinal Health; Incyte; Seagen
Research Funding - AstraZeneca; Incyte; Medically Home
Travel, Accommodations, Expenses - ADC Therapeutics; Cardinal Health
 
Areej El-Jawahri
Stock and Other Ownership Interests - Tuesday Health
Consulting or Advisory Role - AIM Specialty Health; GlaxoSmithKline; Incyte; Novartis
Research Funding - Blue Note Therapeutics
 
Andrea Pusic
Patents, Royalties, Other Intellectual Property - BREASTQ; QPROM Portfolio
 
Jason Liu
Research Funding - National Cancer Institute
 
Therese Mulvey
Consulting or Advisory Role - Cardinal Health; Targeted Oncology
Travel, Accommodations, Expenses - Cardinal Health
 
Joseph Greer
Consulting or Advisory Role - BeiGene
Speakers' Bureau - GlaxoSmithKline
Research Funding - Blue Note Therapeutics (Inst); NCCN/AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Oxford University Press; Royalties from Springer Publishing Company for edited book, "The Massachusetts General Hospital Handbook of Behavioral Medicine."
 
Thomas Roberts
Employment - Bicara Therapeutics (I)
Leadership - Bicara Therapeutics (I); Biocon
Stock and Other Ownership Interests - Bicara Therapeutics (I); Biocon (I); Syngene Ltd. (I)
Research Funding - Coherus Biosciences; Pfizer